Who has invested in Denali Therapeutics?

Sanofi, Biogen, Takeda Pharmaceuticals are named among the investors backing Denali Therapeutics.

Denali Therapeutics Funding: $349M Raised, Series A

Denali Therapeutics funding overview

Denali Therapeutics is based in South San Francisco. Denali Therapeutics has raised $349M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A. Investors on record include Sanofi, Biogen, Takeda Pharmaceuticals. 3 distinct backers are named across the disclosed rounds.

Denali Therapeutics at a glance

Total raised: $349M
Latest round: Series A
Headquarters: South San Francisco
Notable investors: Sanofi, Biogen, Takeda Pharmaceuticals

Frequently asked about Denali Therapeutics funding

How much has Denali Therapeutics raised?: Denali Therapeutics has raised $349M in total disclosed funding across the rounds on record.
Who has invested in Denali Therapeutics?: Sanofi, Biogen, Takeda Pharmaceuticals are named among the investors backing Denali Therapeutics.
What was the latest Denali Therapeutics funding round?: The most recent disclosed round is a Series A.
Where is Denali Therapeutics based?: Denali Therapeutics is based in South San Francisco.

Round data for Denali Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in South San Francisco and backer lists below.

Denali Therapeutics Funding: $349M Raised, Series A

Denali Therapeutics funding overview

Denali Therapeutics at a glance

Frequently asked about Denali Therapeutics funding

Companies related to Denali Therapeutics (36)

Browse related funding lists (3)